ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families
- PMID: 9514597
- DOI: 10.1002/(sici)1096-8628(19980207)81:1<117::aid-ajmg19>3.0.co;2-m
ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families
Abstract
The apolipoprotein E (ApoE) genotype is a significant risk factor and modulator of age of onset of Alzheimer's disease (AD). We analyzed the effect of the ApoE genotype in two distinct early-onset familial AD groups: families with a mutation in the presenilin-1 gene (PS-1) on chromosome 14, and families without a mutation detectable in the PS-1, presenilin-2 (PS-2), and the amyloid precursor protein (APP) gene (non-PS early-onset familial AD). The ApoE genotype is clearly shown not to modulate age of onset in families with a mutation in the PS-1 gene and families with no lesion detectable in either the presenilin or APP gene. The effects of a double dose of ApoE4 on age of onset were not assessed in the PS-1 AD families due to the lack of any affected ApoE4 homozygotes in the sample set; this insufficiency will need to be assessed in further studies. There was no association between the ApoE4 allele and AD in the PS-1 families. Non-PS early-onset AD families were shown to have a significantly higher frequency of ApoE4 compared to controls and the PS-1 AD group. These observations are important and suggest that 1) other genetic and environmental factors modify the AD phenotype in PS-1 and non-PS early-onset families; and 2) the ApoE4 allele is a significant risk factor in the etiology of non-PS early-onset AD and will be a useful adjunct in the diagnosis of unaffected family members.
Similar articles
-
Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.Chin Med J (Engl). 2000 Apr;113(4):340-4. Chin Med J (Engl). 2000. PMID: 11775232
-
Molecular genetics of Alzheimer's disease.Geriatrics. 1997 Sep;52 Suppl 2:S9-12. Geriatrics. 1997. PMID: 9307578 Review.
-
E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.Hum Mutat. 1997;10(3):186-95. doi: 10.1002/(SICI)1098-1004(1997)10:3<186::AID-HUMU2>3.0.CO;2-H. Hum Mutat. 1997. PMID: 9298817
-
Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.Arch Neurol. 2002 Nov;59(11):1759-63. doi: 10.1001/archneur.59.11.1759. Arch Neurol. 2002. PMID: 12433263
-
Exploring the etiology of Alzheimer disease using molecular genetics.JAMA. 1997 Mar 12;277(10):825-31. JAMA. 1997. PMID: 9052714 Review.
Cited by
-
The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.Neuromolecular Med. 2002;2(1):1-10. doi: 10.1385/NMM:2:1:01. Neuromolecular Med. 2002. PMID: 12230301 Review.
-
APOE Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population.Geriatrics (Basel). 2022 Dec 20;8(1):1. doi: 10.3390/geriatrics8010001. Geriatrics (Basel). 2022. PMID: 36648906 Free PMC article.
-
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer's disease.Mol Psychiatry. 2024 Oct;29(10):3040-3055. doi: 10.1038/s41380-024-02565-x. Epub 2024 Apr 24. Mol Psychiatry. 2024. PMID: 38658772 Free PMC article.
-
A multivariate model of time to conversion from mild cognitive impairment to Alzheimer's disease.Geroscience. 2020 Dec;42(6):1715-1732. doi: 10.1007/s11357-020-00260-7. Epub 2020 Sep 4. Geroscience. 2020. PMID: 32886293 Free PMC article.
-
Dissecting the clinical heterogeneity of early-onset Alzheimer's disease.Mol Psychiatry. 2022 Jun;27(6):2674-2688. doi: 10.1038/s41380-022-01531-9. Epub 2022 Apr 7. Mol Psychiatry. 2022. PMID: 35393555 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous